Amanote Research
Register
Sign In
Discover open access scientific publications
Search, annotate, share and cite publications
Publications by Burak Uzunparmak
Comment on “ERK and P38MAPK Combine to Improve Survival in Patients With BRAF Mutant Colorectal Cancer”
British Journal of Cancer
Cancer Research
Oncology
Related publications
Clinical Responses to ERK Inhibition in BRAF V600e-Mutant Colorectal Cancer Predicted Using a Computational Model
npj Systems Biology and Applications
Genetics
Molecular Biology
Biochemistry
Applied Mathematics
Simulation
Computer Science Applications
Modeling
Drug Discovery
Pilot Trial of Combined BRAF and EGFR Inhibition in BRAF-Mutant Metastatic Colorectal Cancer Patients
Clinical Cancer Research
Cancer Research
Oncology
BRAF V600E Mutant Colorectal Cancer Subtypes Based on Gene Expression
Clinical Cancer Research
Cancer Research
Oncology
BRAF-mutant Transcriptional Subtypes Predict Outcome of Combined BRAF, MEK, and EGFR Blockade With Dabrafenib, Trametinib, and Panitumumab in Patients With Colorectal Cancer
Clinical Cancer Research
Cancer Research
Oncology
Association of BRAF Mutations With Survival and Recurrence in Surgically Treated Patients With Metastatic Colorectal Liver Cancer
JAMA Surgery
Surgery
Does Antithrombotic Therapy Improve Survival With Colorectal Cancer?
World Journal of Surgical Oncology
Surgery
Oncology
Comment On: Risk Factors for Survival After Lung Metastasectomy for Colorectal Cancer Patients
Annals of Surgical Oncology
Oncology
Surgery
Molecular Landscape of Acquired Resistance to Targeted Therapy Combinations in BRAF-Mutant Colorectal Cancer
Cancer Research
Cancer Research
Oncology
BRAF Mutant Colorectal Cancer: ErbB2 Expression Levels as Predictive Factor for the Response to Combined BRAF/ErbB Inhibitors
BMC Cancer
Cancer Research
Oncology
Genetics
